BZO-POXIZID |
An analytical reference standard categorized as a synthetic cannabinoid; i… |
5 mg |
34795-5 |
More Info
|
BZO-POXIZID-d9 |
An internal standard for the quantification of BZO-POXIZID by GC- or LC-MS… |
1 mg |
36799-1 |
More Info
|
2-BZP |
An analytical reference standard categorized as a piperazine; intended for… |
1 mg |
24419-1 |
More Info
|
2-BZP |
An analytical reference standard categorized as a piperazine; intended for… |
5 mg |
24419-5 |
More Info
|
Bz-RS-ISer(3-Ph)-OMe |
An intermediate in the synthesis of 7-epi-10-deacetyltaxol |
1 g |
40291-1 |
More Info
|
Bz-RS-ISer(3-Ph)-OMe |
An intermediate in the synthesis of 7-epi-10-deacetyltaxol |
10 g |
40291-10 |
More Info
|
Bz-RS-ISer(3-Ph)-OMe |
An intermediate in the synthesis of 7-epi-10-deacetyltaxol |
5 g |
40291-5 |
More Info
|
246C10 |
An ionizable cationic lipid (pKa = 6.75); has been used in combination wit… |
10 mg |
37907-10 |
More Info
|
246C10 |
An ionizable cationic lipid (pKa = 6.75); has been used in combination wit… |
25 mg |
37907-25 |
More Info
|
246C10 |
An ionizable cationic lipid (pKa = 6.75); has been used in combination wit… |
5 mg |
37907-5 |
More Info
|
680C91 |
A TDO inhibitor (IC50s = 1.46 and 0.28 µM for the mouse and human en… |
10 mg |
34823-10 |
More Info
|
680C91 |
A TDO inhibitor (IC50s = 1.46 and 0.28 µM for the mouse and human en… |
25 mg |
34823-25 |
More Info
|
680C91 |
A TDO inhibitor (IC50s = 1.46 and 0.28 µM for the mouse and human en… |
5 mg |
34823-5 |
More Info
|
680C91 |
A TDO inhibitor (IC50s = 1.46 and 0.28 µM for the mouse and human en… |
50 mg |
34823-50 |
More Info
|
C-02 |
A PROTAC that drives hexokinase 2 degradation; induces degradation of hexo… |
1 mg |
39384-1 |
More Info
|
C-02 |
A PROTAC that drives hexokinase 2 degradation; induces degradation of hexo… |
5 mg |
39384-5 |
More Info
|
C-02 |
A PROTAC that drives hexokinase 2 degradation; induces degradation of hexo… |
500 µg |
39384-500 |
More Info
|
C12-113 |
An ionizable cationic lipidoid; has been used in combination with other li… |
10 mg |
39335-10 |
More Info
|
C12-113 |
An ionizable cationic lipidoid; has been used in combination with other li… |
25 mg |
39335-25 |
More Info
|
C12-113 |
An ionizable cationic lipidoid; has been used in combination with other li… |
5 mg |
39335-5 |
More Info
|
C12-200 |
A branched-chain ionizable cationic lipidoid; has been used in combination… |
10 mg |
36699-10 |
More Info
|
C12-200 |
A branched-chain ionizable cationic lipidoid; has been used in combination… |
100 mg |
36699-100 |
More Info
|
C12-200 |
A branched-chain ionizable cationic lipidoid; has been used in combination… |
25 mg |
36699-25 |
More Info
|
C12-200 |
A branched-chain ionizable cationic lipidoid; has been used in combination… |
50 mg |
36699-50 |
More Info
|
C14-4 |
An ionizable cationic lipid; has been used in the generation of lipid nano… |
1 mg |
38942-1 |
More Info
|
C14-4 |
An ionizable cationic lipid; has been used in the generation of lipid nano… |
10 mg |
38942-10 |
More Info
|
C14-4 |
An ionizable cationic lipid; has been used in the generation of lipid nano… |
5 mg |
38942-5 |
More Info
|
C-170 |
A STING inhibitor; binds to STING, inhibits its palmitoylation, and preven… |
10 mg |
30157-10 |
More Info
|
C-170 |
A STING inhibitor; binds to STING, inhibits its palmitoylation, and preven… |
100 mg |
30157-100 |
More Info
|
C-170 |
A STING inhibitor; binds to STING, inhibits its palmitoylation, and preven… |
25 mg |
30157-25 |
More Info
|
C-170 |
A STING inhibitor; binds to STING, inhibits its palmitoylation, and preven… |
50 mg |
30157-50 |
More Info
|
C-171 |
A STING inhibitor; binds to STING, inhibits its palmitoylation, and preven… |
10 mg |
30159-10 |
More Info
|
C-171 |
A STING inhibitor; binds to STING, inhibits its palmitoylation, and preven… |
100 mg |
30159-100 |
More Info
|
C-171 |
A STING inhibitor; binds to STING, inhibits its palmitoylation, and preven… |
25 mg |
30159-25 |
More Info
|
C-171 |
A STING inhibitor; binds to STING, inhibits its palmitoylation, and preven… |
50 mg |
30159-50 |
More Info
|
C-176 |
A STING inhibitor; reduces STING-, but not RIG-I or TBK1-, mediated IFN-&b… |
10 mg |
25859-10 |
More Info
|
C-176 |
A STING inhibitor; reduces STING-, but not RIG-I or TBK1-, mediated IFN-&b… |
100 mg |
25859-100 |
More Info
|
C-176 |
A STING inhibitor; reduces STING-, but not RIG-I or TBK1-, mediated IFN-&b… |
25 mg |
25859-25 |
More Info
|
C-176 |
A STING inhibitor; reduces STING-, but not RIG-I or TBK1-, mediated IFN-&b… |
50 mg |
25859-50 |
More Info
|
C-178 |
A STING inhibitor; binds to Cys91 on STING to block its and prevents recru… |
10 mg |
25860-10 |
More Info
|
C-178 |
A STING inhibitor; binds to Cys91 on STING to block its and prevents recru… |
25 mg |
25860-25 |
More Info
|
C-178 |
A STING inhibitor; binds to Cys91 on STING to block its and prevents recru… |
5 mg |
25860-5 |
More Info
|
C-178 |
A STING inhibitor; binds to Cys91 on STING to block its and prevents recru… |
50 mg |
25860-50 |
More Info
|
C18 |
A covalent GPX4 inhibitor (IC50 = 120 nM); inhibits the growth of MDA-MB-4… |
1 mg |
39432-1 |
More Info
|
C18 |
A covalent GPX4 inhibitor (IC50 = 120 nM); inhibits the growth of MDA-MB-4… |
10 mg |
39432-10 |
More Info
|
C18 |
A covalent GPX4 inhibitor (IC50 = 120 nM); inhibits the growth of MDA-MB-4… |
25 mg |
39432-25 |
More Info
|
C18 |
A covalent GPX4 inhibitor (IC50 = 120 nM); inhibits the growth of MDA-MB-4… |
5 mg |
39432-5 |
More Info
|
C188-9 |
A STAT3 inhibitor; binds to the STAT3 SH2 domain (Ki = 136 nM) and inhibit… |
10 mg |
30928-10 |
More Info
|
C188-9 |
A STAT3 inhibitor; binds to the STAT3 SH2 domain (Ki = 136 nM) and inhibit… |
25 mg |
30928-25 |
More Info
|
C188-9 |
A STAT3 inhibitor; binds to the STAT3 SH2 domain (Ki = 136 nM) and inhibit… |
5 mg |
30928-5 |
More Info
|